Topic: GlaxoSmithKline plc

U.S. probes Roche, Glaxo diet drug over liver injury

WASHINGTON (Reuters) - U.S. health officials are reviewing reports of liver injury in people who took Roche Holding AG's weight loss drug Xenical or the over-the-counter version sold by GlaxoSmithKline. The Food and Drug Administration said on Monday it had received 32 ...
FDA probes liver damage with alli, only nonprescription weight loss drug approved in USThe Food and Drug Administration is investigating reports of liver damage in patients taking alli, the only nonprescription weight loss drug approved by the agency. Regulators said Monday they ...